Skip to content
Sunil Healthcare logo

Sunil Healthcare

SUNLOC NSE
₹67.90 up 1.91 (2.89%)
Market Cap
₹69.63 Cr
P/E
19.46

Sunil Healthcare (SUNLOC) share price was ₹67.90 at the 28 Oct 2026 close; market capitalisation ₹69.63 Cr; P/E (TTM) 19.46; sector Healthcare. The share price fell 4.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue fell 16.1% year on year to ₹18.99 Cr and net profit fell 49.5% year on year to ₹0.46 Cr (compared with Jun 2025). Promoters held 73.53% of Sunil Healthcare in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 57/100 (Good) as of 28 Oct 2026.

Close 28 Oct 2026 ₹67.90 −3.60 −5.03% 1Y

Key Fundamentals

MicrocapPharmaceuticals & BiotechnologyHealthcare
Market Cap
₹69.63 Cr
P/E (TTM)
19.46
EBITDA
₹14.90 Cr
Return on Equity
5.76%
Debt to Equity
0.85
Book Value
₹52.06
EPS (TTM)
₹3.49
52W High
₹82.00
52W Low
₹56.35

Price-based figures as of 28 Oct 2026, 15:08 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Pharmaceuticals

Sun Pharma
₹1,765.9035.034,23,699 Cr5.070.91%13.79%17.94%61,848 Cr12,117 Cr
Divis Laboratories
₹9,652.0087.602,56,230 Cr15.290.32%15.32%18.96%11,682 Cr2,925 Cr
Torrent Pharmaceuticals
₹4,596.5072.161,74,836 Cr9.520.82%12.16%9.06%17,058 Cr2,156 Cr
Laurus Labs
₹2,190.00108.201,18,328 Cr22.330.09%16.38%19.67%7,323 Cr1,090 Cr
Zydus Life Science
₹1,181.4026.291,17,845 Cr4.350.09%16.99%19.24%28,515 Cr4,593 Cr
Dr Reddys Laboratories
₹1,337.4034.641,11,630 Cr2.880.61%10.87%13.94%34,247 Cr3,184 Cr
Cipla
₹1,363.1032.661,10,119 Cr3.110.96%11.21%14.88%28,589 Cr3,356 Cr
Sunil Healthcare (this company)
₹67.9019.4670 Cr1.300.00%5.76%8.55%86 Cr4 Cr
Median 8 companies₹1,564.5034.841,18,087 Cr4.710.47%12.98%16.41%22,787 Cr3,055 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

57 Good
Overall score

Data confidence 100/100

Category scores

Quality Strong 72
Returns, margins, earnings quality 22% weight
Valuation Good 66
Cheap vs sector & own history 24% weight
Growth Poor 36
Sales & profit trajectory 9% weight
Financial Health Poor 21
Solvency, leverage, coverage 9% weight
Momentum Good 61
Trend strength, vol-adjusted 12% weight
Ownership Average 50
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Stock is trading at 1.03 times its book value

Weaknesses

4
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -0.65% over past five years.
  • Company has a low return on equity of 0.59% over last 3 years.
  • Company has high debtors of 188 days.

Technical Indicators

Oscillators

Neutral

Bearish
1
Neutral
7
Bullish
1

Overall

Bearish

Bearish
8
Neutral
7
Bullish
4

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Growth Rate

Revenue Growth
6.01% higher than 3Y

change over 1 year

Net Income Growth
-386% lower than 3Y

change over 1 year

Cash Flow Change
92.27%

change over 1 year

EBITDA Margin Change
21.4%

change over 1 year Operating margin 15.43% · Jun 2026

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
22.51
23.7
22.67
21.31
21.5
20.26
20.46
21.2
22.64
23.52
21.84
19.72
18.99
Expenses
21.69
22.48
23.3
18.63
19.29
17.95
17.76
18.17
19.37
19.59
18.22
17.78
16.06
Operating Profit
0.82
1.22
-0.63
2.68
2.21
2.31
2.7
3.03
3.27
3.93
3.62
1.94
2.93
OPM %
3.64%
5.15%
-2.78%
12.58%
10.28%
11.4%
13.2%
14.29%
14.44%
16.71%
16.58%
9.84%
15.43%
Other Income
1.19
0.22
3.13
0.68
0.14
0.18
0.53
0.49
0.86
0.42
0.5
0.29
0.23
Interest
1.27
1.31
1.44
1.76
1.51
1.5
1.89
1.56
1.44
1.4
1.66
1.66
1.5
Depreciation
1.61
1.59
1.45
1.43
1.48
1.51
1.69
1.68
1.66
1.64
1.62
1.52
1.46
PBT
-0.87
-1.46
-0.39
0.17
-0.64
-0.52
-0.35
0.28
1.03
1.31
0.84
-0.95
0.2
Tax %
-26.44%
-25.34%
-48.72%
5.88%
6.25%
7.69%
57.14%
-28.57%
11.65%
23.66%
30.95%
-258.95%
-130%
Net Profit
-0.64
-1.1
-0.2
0.15
-0.69
-0.55
-0.54
0.36
0.91
1
0.59
1.52
0.46
EPS (₹)
-0.62
-1.07
-0.2
0.15
-0.67
-0.54
-0.53
0.35
0.89
0.98
0.58
1.48
0.45
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
108
91.33
80.88
70.02
90.62
119
110
90.19
83.42
87.72
84.07
Expenses
93.33
77.44
69.62
76.95
85.27
102
94.32
85.93
73.06
74.95
71.65
Operating Profit
15.15
13.89
11.26
-6.93
5.35
17.38
16.17
4.26
10.36
12.77
12.42
OPM %
13.97%
15.21%
13.92%
-9.9%
5.9%
14.59%
14.63%
4.72%
12.42%
14.56%
14.77%
Other Income
1.25
2.23
0.18
14.41
5.52
1.68
4.5
5.05
1.24
2.06
1.44
Interest
4.18
5.03
6.58
6.95
5.31
3.49
4.17
5.78
6.46
6.16
6.22
Depreciation
4.33
4.78
5.74
6.13
6.11
6.31
7.01
6.09
6.35
6.44
6.24
PBT
7.89
6.31
-0.88
-5.6
-0.55
9.26
9.49
-2.56
-1.21
2.23
1.4
Tax %
36.25%
28.68%
-20.45%
-11.25%
16.36%
30.67%
29.5%
-30.08%
16.53%
-79.37%
—
Net Profit
5.03
4.49
-0.69
-4.96
-0.64
6.42
6.68
-1.79
-1.42
4.01
3.57
EPS (₹)
4.91
4.38
-0.67
-4.84
-0.62
6.26
6.51
-1.75
-1.38
3.91
3.49
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
10.25
Reserves
32.65
37.18
36.52
34.34
33.46
39.7
45.74
57.96
56.81
59.35
Borrowings
44.53
60.62
55.08
49.45
49.82
34.68
36.79
66.15
68.65
59.37
Other Liabilities
31.41
34.16
35.88
36.19
27.03
25.06
28.01
24.13
26.23
35.53
Total Liabilities
119
142
138
130
121
110
121
158
162
165
Fixed Assets
59.72
70.92
68.83
69.97
69.8
69.97
70.43
87.16
94.08
85.85
CWIP
0.12
0.19
2.47
0.01
0.01
1.75
0.01
5.66
0.09
1.77
Investments
0
0.1
0.11
0.11
1.07
1.03
0
0
0
0
Other Assets
59
71
66.32
60.14
49.68
36.94
50.35
65.67
67.77
76.88
Total Assets
119
142
138
130
121
110
121
158
162
165
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
10.79
5.48
14.73
4.31
16.99
22.51
7.47
-15.4
11.52
22.15
Investing
-12.85
-17.18
-2.8
-2.52
-11.36
-4.24
-3.4
-10.11
-7.7
-2.85
Financing
2.23
11.02
-11.63
-1.56
-6.42
-18.56
-3.75
25
-3.87
-19.26
Net Cash Flow
0.17
-0.67
0.3
0.23
-0.79
-0.29
0.32
-0.51
-0.05
0.04
Free Cash Flow
-2.15
-10.13
9.22
3.63
10.28
13.49
3.99
-25.58
2.52
18.6
CFO/OP
82
50
134
-64
315
136
55
-344
111
175
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
130
192
177
123
94.37
57.86
93.85
164
182
188
Inventory Days
76.09
102
213
323
117
83.25
105
111
172
209
Days Payable
139
180
294
293
109
65.01
114
47.85
86.82
178
Cash Conversion Cycle
66.75
114
96.04
153
102
76.09
84.96
227
267
219
Working Capital Days
-11.68
-16.43
-50.91
-63.65
-53.49
-25.91
-4.33
6.35
-2.54
21.6
ROCE %
—
11.6%
5.43%
1.65%
5.12%
14.25%
15.3%
2.98%
3.96%
6.43%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sunil Healthcare insights

71 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

DIIs0.10%Promot.73.53%Others8.49%Public17.87%As ofSep 2026

Documents

1
Concall - Jul 2021 Jul 2021
2
Concall - May 2021 May 2021
3
Concall - May 2021 May 2021
4
Concall - May 2021 May 2021
5
Concall - Feb 2021 Feb 2021

Frequently Asked Questions about Sunil Healthcare

What does Sunil Healthcare Ltd do?
Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]
Where is Sunil Healthcare Ltd (SUNLOC) listed?
Sunil Healthcare Ltd trades as SUNLOC on the NSE and under code 537253 on the BSE.
Which sector does Sunil Healthcare Ltd belong to?
Sunil Healthcare Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sunil Healthcare Ltd?
Sunil Healthcare Ltd has a market capitalisation of ₹69.63 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the PE ratio of Sunil Healthcare Ltd?
Sunil Healthcare Ltd trades at a PE ratio of 19.46 as of 28 Oct 2026, on earnings per share of ₹3.49, against a book value of ₹52.06 per share.
What is the 52-week high and low of Sunil Healthcare Ltd?
Over the last 52 weeks Sunil Healthcare Ltd has traded between ₹56.35 and ₹82 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Sunil Healthcare Ltd?
Sunil Healthcare Ltd reported a return on equity of 5.76%. Its debt-to-equity ratio is 0.85.

Company Information

Incorporated in 1976, Sunil Healthcare Ltd is a certified manufacturer of Empty Hard Gelatin capsules shell and HPMC Capsules shell.[1]

Website sunilhealthcare.com
Listed 2026-08-17
Face Value ₹ 10
Shares Outstanding 1,02,54,750

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/537253.md for Sunil Healthcare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Pharma stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month